Open AccessImproved Speech Intelligibility in Subjects With Stable Sensorineural Hearing Loss Following Intratympanic Dosing of FX-322 in a Phase 1b Study
Author(s) -
Will J. McLean,
Ashley Hinton,
Jenna Herby,
Alec N. Salt,
Jared J. Hartsock,
S. G. Wilson,
David L. Lucchino,
Thomas Lenarz,
Athanasia Warnecke,
Nils Prenzler,
H. Schmitt,
Susan King,
Lance E. Jackson,
Jeffrey Rosenbloom,
George Atiee,
Moraye B. Bear,
Christina L. Runge-Samuelson,
René H. Gifford,
Steven D. Rauch,
Dong Hoon Lee,
Robert Langer,
Jeffrey M. Karp,
Christopher Loose,
Carl LeBel
Publication year - 2021
Publication title -
otology and neurotology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.147
H-Index - 104
eISSN - 1537-4505
pISSN - 1531-7129
DOI - 10.1097/mao.0000000000003120
Subject(s) - medicine , perilymph , sensorineural hearing loss , hearing loss , placebo , dosing , adverse effect , audiology , anesthesia , cochlea , pathology , alternative medicine